Glutamate system is modified by ethanol and contributes both to the euphoric and the dysphoric consequences of intoxication, but there is now growing evidence that the glutamatergic system also plays a central role in the neurobiology and treatment of mood disorders, including major depressive disorders and bipolar disorders.We speculate that, using acamprosate, patients with bipolar depression (BIP-A) can take advantage of the anti-glutamate effect of acamprosate to “survive” in treatment longer than peers suffering from non-bipolar depression (NBIP-A) after detoxification.
Autori interni: | |
Autori: | Maremmani, Angelo Giovanni Icro; Bacciardi, Silvia; Rovai, Luca; Rugani, Fabio; Massimetti, Enrico; Gazzarrini, Denise; Dell'Osso, Liliana; Maremmani, Icro |
Titolo: | Six-month outcome in bipolar spectrum alcoholics treated with acamprosate after detoxification: a retrospective study |
Anno del prodotto: | 2014 |
Abstract: | Glutamate system is modified by ethanol and contributes both to the euphoric and the dysphoric consequences of intoxication, but there is now growing evidence that the glutamatergic system also plays a central role in the neurobiology and treatment of mood disorders, including major depressive disorders and bipolar disorders.We speculate that, using acamprosate, patients with bipolar depression (BIP-A) can take advantage of the anti-glutamate effect of acamprosate to “survive” in treatment longer than peers suffering from non-bipolar depression (NBIP-A) after detoxification. |
Digital Object Identifier (DOI): | 10.3390/ijerph111212983 |
Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
DellOsso_800469.pdf | Versione finale editoriale | ![]() | Open AccessVisualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.